Funded Tech Companies
Pan Cancer T
Looking for the VC firms that invested in Pan Cancer T? Thuja Capital and InnovationQuarter Capital joined the equity holders in this life sciences company.
Company Overview
Company Name
Pan Cancer T
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
Marconistraat 16
Rotterdam, 3029
The Netherlands
Rotterdam, 3029
The Netherlands
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Pan Cancer T is an immunotherapy company developing next-generation TCR-T cell therapies for solid cancer. The Company´s products are based on a form of T cell therapy called TCR-T therapy. It exploits the abilities of T cells -- the primary natural immune effector cell -- to recognize and kill tumor cells.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/11/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rachel Abbott
Chief Financial Officer
Lars Ottevanger
Chief Medical Officer
Tom Holdich
VP - Bus. Development
Reinout Hesselink
VP - R & D
Dora Hammerl
Company Investors
- Thuja Capital
- InnovationQuarter Capital (Nina Satih)
Browse more funded tech companies:
Share this article
About Our VC & M&A Database
Our data comes from VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs